Press-release for stocks for novo nordisk a/s

Prices are updated after-hours

Outcome of Innate Pharma’s Annual General Meeting
Published: 2021-05-28 (Crawled : 22:00) - globenewswire.com
IPHA | $2.48 5.53% 5.24% 9.4K

| Email alert Add to watchlist
NVO | News | $122.71 -0.03% 0.17% 5M

| Email alert Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M

Novo Nordisk resubmits once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes for US regulatory approval
Published: 2021-05-28 (Crawled : 15:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M

| 55.68% | O: -0.01% H: 0.93% C: 0.11%
diabetes treatment approval

BioSpace Movers & Shakers, May 28
Published: 2021-05-28 (Crawled : 13:15) - biospace.com/
VECT | $16.85 0.12% 130K

| 14.31% | O: -0.07% H: 2.65% C: 1.15%
NVO | News | $122.71 -0.03% 0.17% 5M

| 55.68% | O: -0.01% H: 0.93% C: 0.11%
JNJ | News | $147.91 1.49% -0.03% 9.6M

| -12.38% | O: 0.42% H: 0.88% C: -0.16%
QURE | $4.68 -0.64% -0.64% 550K

| -86.62% | O: -1.75% H: 3.14% C: 1.31%
space spac

67%

33%

Save your searches and get alerts when important news are released.